The truth. A must read if you work at Genentech!



















Roche has already milked Genentech all it could from the 3 block busters in the past decades. Genentech means absolutely nothing in Basel right now. It is certainly nothing more than an expensive line item . A few years ago they added "A Member of the Roche Group" in your business cards. They are already making plans to change it to Roche Genentech very soon. The final step is to remove Genentech all together. It has something to do with finance. I don't have the exact timeline but it will eventually happen. For those of you who are DNA loyalists ( I don't think there are too many left), I am sorry.
 






Roche has already milked Genentech all it could from the 3 block busters in the past decades. Genentech means absolutely nothing in Basel right now. It is certainly nothing more than an expensive line item . A few years ago they added "A Member of the Roche Group" in your business cards. They are already making plans to change it to Roche Genentech very soon. The final step is to remove Genentech all together. It has something to do with finance. I don't have the exact timeline but it will eventually happen. For those of you who are DNA loyalists ( I don't think there are too many left), I am sorry.
 






A few years ago they added "A Member of the Roche Group" in your business cards. They are already making plans to change it to Roche Genentech very soon. The final step is to remove Genentech all together.


If you recall, on one of the large calls earlier this year (can't remember which one as the beatings all start to run together) the speaker used the term "One Roche". That was the first time I had heard that. I wouldn't be surprised if you are correct.
 












how many of these systems are there

Ecosystem are so stupid. 2nd Quarter worst since 2011. $5 billion loss from rapid adoption of Biosims and Covid impact. No adjustments in Revenue guidance = tons of pressure on a completely unproven sales model. No one knows what they are doing. This is not going to end well. D
 






OG author here – someone saw fit to copy the first post from another thread. Thank you for that.

I know that I said I would not be back, but due to the above this has kind of taken on a life of its own, and from what I heard is being “countered” by leadership as rumor only. So I am coming back to breathe more life into the situation to help the folks out there that may be questioning the validity of the above. My advice: “don’t drink the koolaid”. Acquiring the details of this information will require some homework on the readers part though…

All GNE field: Start asking questions to your NSDs (not RSDs or DMs) about how the current sizing structure does not account for everything – especially access restricted accounts. What has the “research” shown that is need to fully account for the above?

BioOnc field: Start asking questions to your NSDs (not RSDs or DMs) about what this acronym means “CSS”. The name of the pilot I referenced in the first post has changed. It is still coming but will be called something else, but I am not sure what. Execution timeline still the same as of now - Sept/Oct timeframe.

HomeOffice: The outcome of the two things above should be all of evidence you need to know that my original post is accurate. Massive changes in the field structure necessitate massive changes in the commercial HO structure, stop being delusional.

Message to Sr. Leadership: If you want to know who is leaking this information…look in the mirror. On the one hand I admire you all selectively sharing information with others – I am confident this is related to feelings of guilt for those to be impacted. On the other hand, you can do more. Be transparent with the direction things are going – give folks a warning so not blindsided. Follow GC example to AHR…

Message to VPs & up: Look around – trust in people leaders is no longer implicit in this country. This has to be earned and the foundation of that trust is transparency which you are not being at the moment, hence the growing lack of trust in you. Everyone knows that secrets are impossible to keep at GNE especially ones of this magnitude. You seem to be operating under the premise of decision making akin to “it’s not personal, it’s just business”. Let me enlighten you: business is one of the most personal things in life. First off GNE is made of people and without people the business would not exist, ergo “people = personal”. Second, business generates employment which gives income to people to support themself and family. Also, business generates opportunities to develop relationships with others. When a “business decision” gets made that results in loss of employment that decision directly impacts the people, their families, and their personal relationships with colleagues. business = personal

For others that continuing to read the “it’s not personal, it’s just business” mantra is a lame excuse used by people not being impacted by the decisions being made. When folks making those decisions are also going to be impacted (see mirror comment above), they will likely still make the decision but they will invariably share information with others either out of guilt or frustration with the situation.

Message to Chief AH: You came back to GNE with a glowing legacy which brought hope to the masses. Your predecessor started “Transformation” – don’t let transformation be YOUR legacy. Reach back to your IMPACT days and bring out some of that genuine leadership you displayed with Pegasys - everyone is watching...
 






As a non-GNE employee, I've heard a lot of noise about this new "ecosystem". Can someone explain what this actually means to customers? Do they now have a single point of contact?
 






The truth is sometimes hard to absorb, but needs to be told:

BioOnc will be the first to go and suffer the deepest cuts 50%-65% of sales force. DMs and RSDs are not in the loop because ALL of their roles will be eliminated(i.e. no CS, DM, RSD -- all new role categories, so everyone will have to interview). So even if you ask, they won't know. Look forward to a "pilot" announcement in the next six weeks. The structure of the upcoming pilot and what has been rolled out as HSE is a glimpse into the future structure . Don't get too comfortable as the future is 2H'21 - after AHR sales have completely fallen off cliff. BioOnc may go fully with pilot before then though, so polish your resumes folks. (If you're entire career has been in sales / sales leadership - your chance of survival is next to zero.) The rest of the field organization will suffer no later than 2H'21 - compliments of CEoF. The home office folks (including me) will suffer the same fate in 1H'21 - all new role categories here too and interviews for everyone. I plan on taking the package when it comes, as my role will be gone too.

If you question the validity of the above - read every email / G+ site you can about CEoF, C3PO, HSE, new Lucentis structure (safe unless PDS doesnt make it). All of the puzzle pieces are there - you just need to take a step back and consider all at once. The timeline, well you are just gonna have to trust me (not set in stone but I am close).

I have nothing to gain by sharing this info - I am not a cafepharma troll nor a competitor. I genuinely care about other people and I could not live with myself if I did not share what I knew about the impact these changes will have on people's lives. Hopefully word will spread from here and it will help at least a few folks. This is the only post I will make and I will not check back to answer any questions. I replied here rather than starting a new thread so it wont cause any immediate red flags in SSF.

Even if you ignore the warning above, heed this: This is a "for profit" organization and the folks leading are responsible for delivering results or their @ss is out. People will always do what is in their own best interest professionally when pushed in a corner - I don't blame them I have a family too. To that end, $9B annual revenue will be gone in three years and GNE will not get that back until 2025. Don't delude yourself - massive cuts are coming. No one is safe unless they have "VP" in their title.

You have been warned... I wish you all good luck in "Transformation"

You were warned! If you're surprised - shame on you. Home office is going to shrink dramatically. Get that resume updated.
 






The truth is sometimes hard to absorb, but needs to be told:

BioOnc will be the first to go and suffer the deepest cuts 50%-65% of sales force. DMs and RSDs are not in the loop because ALL of their roles will be eliminated(i.e. no CS, DM, RSD -- all new role categories, so everyone will have to interview). So even if you ask, they won't know. Look forward to a "pilot" announcement in the next six weeks. The structure of the upcoming pilot and what has been rolled out as HSE is a glimpse into the future structure . Don't get too comfortable as the future is 2H'21 - after AHR sales have completely fallen off cliff. BioOnc may go fully with pilot before then though, so polish your resumes folks. (If you're entire career has been in sales / sales leadership - your chance of survival is next to zero.) The rest of the field organization will suffer no later than 2H'21 - compliments of CEoF. The home office folks (including me) will suffer the same fate in 1H'21 - all new role categories here too and interviews for everyone. I plan on taking the package when it comes, as my role will be gone too.

If you question the validity of the above - read every email / G+ site you can about CEoF, C3PO, HSE, new Lucentis structure (safe unless PDS doesnt make it). All of the puzzle pieces are there - you just need to take a step back and consider all at once. The timeline, well you are just gonna have to trust me (not set in stone but I am close).

I have nothing to gain by sharing this info - I am not a cafepharma troll nor a competitor. I genuinely care about other people and I could not live with myself if I did not share what I knew about the impact these changes will have on people's lives. Hopefully word will spread from here and it will help at least a few folks. This is the only post I will make and I will not check back to answer any questions. I replied here rather than starting a new thread so it wont cause any immediate red flags in SSF.

Even if you ignore the warning above, heed this: This is a "for profit" organization and the folks leading are responsible for delivering results or their @ss is out. People will always do what is in their own best interest professionally when pushed in a corner - I don't blame them I have a family too. To that end, $9B annual revenue will be gone in three years and GNE will not get that back until 2025. Don't delude yourself - massive cuts are coming. No one is safe unless they have "VP" in their title.

You have been warned... I wish you all good luck in "Transformation"

It's sad that some of you in the home office will have no reason to return to Genentech Campus again since you'll be receiving notice in the next couple months during WFH. I'm sorry that I, and other leaders, disappointed you.
 






It's sad that some of you in the home office will have no reason to return to Genentech Campus again since you'll be receiving notice in the next couple months during WFH. I'm sorry that I, and other leaders, disappointed you.

Not sad at all. It is well deserve. If you got groups twiddling their thumbs facing a computer. That means there’s no meaningful work. It’s time to go!
 






Genentech was a phenomenon. How often do you see a company with a handful of multi $billion products with almost no competition for such a long time? Money came in faster than they could deposit it. We milked the system like a bandit. It paid for all the perks and thoughtless hiring to make our inept leaders feel good about themselves. Then we fell asleep and the competitors sneaked up on us. Then biosimilars nailed the coffin. So this is it. With the quality of our current management, there will not be a Genentech V2.0. Time to wake up and face the harsh reality. Now Genentech is just another pharma who s is struggling to stay afloat. So more cuts will be coming to your neighborhood. And Dean, you will have your turn too. It is called Karma.
 






Genentech was a phenomenon. How often do you see a company with a handful of multi $billion products with almost no competition for such a long time? Money came in faster than they could deposit it. We milked the system like a bandit. It paid for all the perks and thoughtless hiring to make our inept leaders feel good about themselves. Then we fell asleep and the competitors sneaked up on us. Then biosimilars nailed the coffin. So this is it. With the quality of our current management, there will not be a Genentech V2.0. Time to wake up and face the harsh reality. Now Genentech is just another pharma who s is struggling to stay afloat. So more cuts will be coming to your neighborhood. And Dean, you will have your turn too. It is called Karma.

Anyone else feel like taking a shower when Dean makes an appearance? Something off with the guy